Aseptic Technologies’ Crystal Closed Vial Technology reduces the risk of contamination during the compounding process, using lasers to reseal vials once they have been filled with medication.
“This technology represents a revolutionary advance for Cantrell Drug Company, as well as for the sterile product industry in general,” said Dell McCarley, CEO of Cantrell Drug Company.
More articles on pharmaceuticals:
FDA warns not to use sterile products from Downing Labs due to lack of quality assurance
340B Program: Time to recertify
Pharma recalls steady, but increasing in complexity
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.